Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Living Cell Technologies ( (AU:1AI) ) just unveiled an announcement.
Algorae Pharmaceuticals Limited has announced a new issuance of securities, with 364,327 ordinary fully paid securities set to be quoted on the Australian Securities Exchange (ASX) under the code 1AI. This move is part of the company’s strategic financial operations, potentially impacting its market positioning and providing stakeholders with insights into its growth and expansion strategies.
More about Living Cell Technologies
YTD Price Performance: 30.0%
Average Trading Volume: 2,896,219
Technical Sentiment Signal: Buy
Current Market Cap: A$21.95M
Find detailed analytics on 1AI stock on TipRanks’ Stock Analysis page.